Developmental defect during embryogenesis
MONDO:0019755A disease that has its basis in the disruption of embryonic morphogenesis.
Also known as: congenital malformation syndrome, developmental defect during embryogenesis, disorder of embryonic morphogenesis, embryonic morphogenesis disease, malformation syndrome, rare developmental defect during embryogenesis
1057 clinical trials for this condition and its sub-types, 8 tagged with Developmental defect during embryogenesis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Developmental defect during embryogenesis
-
Developmental anomaly of metabolic origin 0 trials · 383 incl. sub-types
57 sub-types
- Inborn mitochondrial metabolism disorder 59 trials · 127 incl. sub-types Sub-types →
- Fabry disease 64 trials
- Mucopolysaccharidosis 14 trials · 61 incl. sub-types Sub-types →
- Sterol biosynthesis disorder 0 trials · 45 incl. sub-types Sub-types →
- Fanconi anemia 29 trials · 42 incl. sub-types Sub-types →
- Hypophosphatasia 13 trials Sub-types →
- Oligosaccharidosis 0 trials · 11 incl. sub-types Sub-types →
- Pseudohypoparathyroidism 8 trials · 9 incl. sub-types Sub-types →
- Zellweger spectrum disorders 6 trials · 7 incl. sub-types Sub-types →
- Cockayne syndrome 6 trials Sub-types →
- Creatine transporter deficiency 6 trials
- Mucolipidosis 4 trials · 5 incl. sub-types Sub-types →
- Classic homocystinuria 4 trials
- Mucosulfatidosis 4 trials
- 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency 2 trials
- AICA-ribosiduria 1 trial
- Nijmegen breakage syndrome 1 trial
- SLC35A2-congenital disorder of glycosylation 1 trial
- Arthrogryposis-renal dysfunction-cholestasis syndrome 1 trial Sub-types →
- Encephalopathy due to sulfite oxidase deficiency 0 trials · 1 incl. sub-types Sub-types →
- Occipital horn syndrome 1 trial
- ALDH18A1-related de Barsy syndrome 0 trials
- Al-Gazali syndrome 0 trials
- B4GALT1-congenital disorder of glycosylation 0 trials
- CADDS 0 trials
- CHIME syndrome 0 trials
- COG1-congenital disorder of glycosylation 0 trials
- COG7-congenital disorder of glycosylation 0 trials
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- Ehlers-Danlos syndrome, spondylodysplastic type 0 trials Sub-types →
- Larsen-like syndrome, B3GAT3 type 0 trials
- MGAT2-congenital disorder of glycosylation 0 trials
- Neu-Laxova syndrome 0 trials Sub-types →
- Nijmegen breakage syndrome-like disorder 0 trials
- Peters plus syndrome 0 trials
- RFT1-congenital disorder of glycosylation 0 trials
- SHORT syndrome 0 trials
- SLC39A8-CDG 0 trials
- SSR4-congenital disorder of glycosylation 0 trials
- Wiedemann-Rautenstrauch syndrome 0 trials
- XYLT1-congenital disorder of glycosylation 0 trials
- Autism spectrum disorder - epilepsy - arthrogryposis syndrome 0 trials
- Autosomal recessive cutis laxa type 2 0 trials Sub-types →
- Cutis laxa, autosomal dominant 3 0 trials
- Developmental and epileptic encephalopathy, 77 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 15 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Mandibuloacral dysplasia 0 trials Sub-types →
- Mucopolysaccharidosis-plus syndrome 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 1 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 3 0 trials
- Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome 0 trials
- Pontocerebellar hypoplasia type 1 0 trials Sub-types →
- Progressive hypotonia-intellectual disability-facial dysmorphism syndrome due to FYVE-defective RBSN 0 trials
- Temtamy preaxial brachydactyly syndrome 0 trials
- Transketolase deficiency 0 trials
-
Multiple congenital anomalies/dysmorphic syndrome 1 trial · 288 incl. sub-types
5 sub-types
- Multiple congenital anomalies/dysmorphic syndrome without intellectual disability 0 trials · 163 incl. sub-types Sub-types →
- Multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome 0 trials · 90 incl. sub-types Sub-types →
- Multiple congenital anomalies/dysmorphic syndrome-intellectual disability 1 trial · 59 incl. sub-types Sub-types →
- Multiple congenital anomalies due to 14q32.2 imprinting defect 0 trials · 2 incl. sub-types Sub-types →
- NR2F2 related multiple congenital anomalies/dysmorphic syndrome 0 trials
-
Neurofibromatosis type 1 73 trials
3 sub-types
-
Congenital limb malformation 3 trials · 61 incl. sub-types
107 sub-types
- Familial clubfoot with or without associated lower limb anomalies 0 trials · 18 incl. sub-types Sub-types →
- Acrocephalosyndactyly 0 trials · 13 incl. sub-types Sub-types →
- Arthrogryposis syndrome 0 trials · 8 incl. sub-types Sub-types →
- Cornelia de Lange syndrome 4 trials · 5 incl. sub-types Sub-types →
- Rubinstein-Taybi syndrome 3 trials Sub-types →
- Poland syndrome 2 trials
- Extensor tendons of finger anomalies 2 trials
- 2q37 microdeletion syndrome 1 trial
- Duane-radial ray syndrome 1 trial Sub-types →
- EEC syndrome 1 trial Sub-types →
- Acrofacial dysostosis 0 trials · 1 incl. sub-types Sub-types →
- Femur-fibula-ulna complex 1 trial
- Laurin-Sandrow syndrome 1 trial
- Proximal symphalangism 1 trial Sub-types →
- Thalidomide embryopathy 1 trial
- Thrombocytopenia-absent radius syndrome 1 trial
- ADULT syndrome 0 trials
- Adams-Oliver syndrome 0 trials Sub-types →
- Al-Gazali syndrome 0 trials
- Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome 0 trials
- Brachymorphism-onychodysplasia-dysphalangism syndrome 0 trials
- Cenani-Lenz syndactyly syndrome 0 trials
- Cooks syndrome 0 trials
- EEM syndrome 0 trials
- Emery-Nelson syndrome 0 trials
- Fuhrmann syndrome 0 trials
- Gollop-Wolfgang complex 0 trials
- Hypoglossia-hypodactyly syndrome 0 trials
- IVIC syndrome 0 trials
- Karsch-Neugebauer syndrome 0 trials
- Keutel syndrome 0 trials
- Leri pleonosteosis 0 trials
- Mononen-Karnes-Senac syndrome 0 trials
- OSLAM syndrome 0 trials
- Say-field-Coldwell syndrome 0 trials
- Sugarman brachydactyly 0 trials
- TELO2-related intellectual disability-neurodevelopmental disorder 0 trials
- Townes-Brocks syndrome 0 trials Sub-types →
- Absence deformity of leg-cataract syndrome 0 trials
- Absent radius-anogenital anomalies syndrome 0 trials
- Absent tibia-polydactyly-arachnoid cyst syndrome 0 trials
- Acromesomelic dysplasia 2B 0 trials
- Acropectoral syndrome 0 trials
- Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome 0 trials Sub-types →
- Aphalangy-syndactyly-microcephaly syndrome 0 trials
- Autosomal recessive amelia 0 trials
- Brachydactyly-arterial hypertension syndrome 0 trials
- Brachydactyly-preaxial hallux varus syndrome 0 trials
- Brachytelephalangy-dysmorphism-Kallmann syndrome 0 trials
- Camptodactyly syndrome, Guadalajara type 2 0 trials
- Camptodactyly-taurinuria syndrome 0 trials
- Caudal regression-sirenomelia spectrum 0 trials Sub-types →
- Cocoon syndrome 0 trials
- Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome 0 trials
- Crossed polysyndactyly 0 trials
- Ectrodactyly-polydactyly syndrome 0 trials
- Familial digital arthropathy-brachydactyly 0 trials
- Femoral-facial syndrome 0 trials
- Fibular aplasia, tibial campomelia, and oligosyndactyly syndrome 0 trials
- Fibular aplasia-ectrodactyly syndrome 0 trials
- Fibular dimelia-diplopodia syndrome 0 trials
- Hallux varus-preaxial polysyndactyly syndrome 0 trials
- Hand-foot-genital syndrome 0 trials
- Heart-hand syndrome 0 trials Sub-types →
- Hereditary thrombocytosis with transverse limb defect 0 trials
- Humerus trochlea aplasia 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability-brachydactyly-Pierre Robin syndrome 0 trials
- Intellectual disability-spasticity-ectrodactyly syndrome 0 trials
- Lethal faciocardiomelic dysplasia 0 trials
- Limb transversal defect-cardiac anomaly syndrome 0 trials
- Mammary-digital-nail syndrome 0 trials
- Microcephaly-brachydactyly-kyphoscoliosis syndrome 0 trials
- Multiple synostoses syndrome 0 trials Sub-types →
- Omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome 0 trials
- Pelvis-shoulder dysplasia 0 trials
- Pelviscapular dysplasia 0 trials
- Phocomelia, Schinzel type 0 trials
- Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome 0 trials
- Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome 0 trials
- Postaxial tetramelic oligodactyly 0 trials
- Radial deficiency-tibial hypoplasia syndrome 0 trials
- Radio-renal syndrome 0 trials
- Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome 0 trials Sub-types →
- Radioulnar synostosis-developmental delay-hypotonia syndrome 0 trials
- Rapadilino syndrome 0 trials
- Scalp defects-postaxial polydactyly syndrome 0 trials
- Shoulder and thorax deformity-congenital heart disease syndrome 0 trials
- Skeletal dysplasia-epilepsy-short stature syndrome 0 trials
- Splenogonadal fusion-limb defects-micrognathia syndrome 0 trials
- Split hand-foot malformation 1 with sensorineural hearing loss 0 trials
- Split-foot malformation-mesoaxial polydactyly syndrome 0 trials
- Symphalangism with multiple anomalies of hands and feet 0 trials
- Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome 0 trials
- Syndactyly-telecanthus-anogenital and renal malformations syndrome 0 trials
- Tarsal-carpal coalition syndrome 0 trials
- Temtamy preaxial brachydactyly syndrome 0 trials
- Tetraamelia-multiple malformations syndrome 0 trials Sub-types →
- Tetramelic monodactyly 0 trials
- Thumb stiffness-brachydactyly-intellectual disability syndrome 0 trials
- Tibia, hypoplasia or aplasia of, with polydactyly 0 trials
- Tibial aplasia-ectrodactyly syndrome 0 trials Sub-types →
- Triphalangeal thumb-polysyndactyly syndrome 0 trials
- Triphalangeal thumbs-brachyectrodactyly syndrome 0 trials
- Ulna hypoplasia-intellectual disability syndrome 0 trials
- Ulnar hypoplasia-split foot syndrome 0 trials
- Ulnar/fibula ray defect-brachydactyly syndrome 0 trials
-
Disorder of sexual differentiation 9 trials · 53 incl. sub-types
7 sub-types
- Sex chromosome disorder of sex development 2 trials · 33 incl. sub-types Sub-types →
- 46,XY disorder of sex development 3 trials · 9 incl. sub-types Sub-types →
- Gynecomastia disorder 6 trials · 8 incl. sub-types Sub-types →
- 46,XX ovotesticular disorder of sex development 1 trial
- Indeterminate sex and/or pseudohermaphroditism 1 trial Sub-types →
- 46,XX disorder of sex development 0 trials Sub-types →
- True hermaphroditism 0 trials
-
Central nervous system malformation 5 trials · 51 incl. sub-types
54 sub-types
- Neural tube defect 12 trials · 23 incl. sub-types Sub-types →
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes 0 trials · 10 incl. sub-types Sub-types →
- Hoyeraal-Hreidarsson syndrome 3 trials
- Pontocerebellar hypoplasia 1 trial · 3 incl. sub-types Sub-types →
- Lhermitte-Duclos disease 2 trials
- PHACE syndrome 2 trials
- Joubert syndrome with oculorenal defect 1 trial Sub-types →
- Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder 1 trial
- Cystic malformation of the posterior fossa 0 trials · 1 incl. sub-types Sub-types →
- Syndromic X-linked intellectual disability 5 1 trial
- Aase-Smith syndrome 0 trials
- B4GALT1-congenital disorder of glycosylation 0 trials
- Dandy-Walker malformation-postaxial polydactyly syndrome 0 trials
- Gomez-Lopez-Hernandez syndrome 0 trials
- Joubert syndrome with ocular defect 0 trials Sub-types →
- NPHP3-related Meckel-like syndrome 0 trials
- Ritscher-Schinzel syndrome 0 trials Sub-types →
- SLC39A8-CDG 0 trials
- TELO2-related intellectual disability-neurodevelopmental disorder 0 trials
- X-linked cerebral-cerebellar-coloboma syndrome syndrome 0 trials
- X-linked intellectual disability-cerebellar hypoplasia syndrome 0 trials
- X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome 0 trials
- Aprosencephaly cerebellar dysgenesis 0 trials
- Arachnoid cyst 0 trials Sub-types →
- Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome 0 trials
- Autosomal recessive spinocerebellar ataxia 20 0 trials
- Cerebellar-facial-dental syndrome 0 trials
- Cerebral gigantism-jaw cysts syndrome 0 trials
- Cervical hypertrichosis-peripheral neuropathy syndrome 0 trials
- Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome 0 trials
- Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome 0 trials
- Facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome 0 trials
- Glioependymal/ependymal cyst 0 trials
- Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome 0 trials
- Hereditary cerebral malformation 0 trials
- Holoprosencephaly-caudal dysgenesis syndrome 0 trials
- Holoprosencephaly-hypokinesia-congenital contractures syndrome 0 trials
- Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0 trials
- Isolated arhinencephaly 0 trials
- Isolated bilateral hemispheric cerebellar hypoplasia 0 trials
- Isolated cerebellar vermis agenesis 0 trials Sub-types →
- Isolated cerebellar vermis hypoplasia 0 trials
- Isolated unilateral hemispheric cerebellar hypoplasia 0 trials
- Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome 0 trials
- Macrocephaly-short stature-paraplegia syndrome 0 trials
- Orofaciodigital syndrome type 6 0 trials
- Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome 0 trials
- Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome 0 trials
- Pontine tegmental cap dysplasia 0 trials
- Rhombencephalosynapsis 0 trials
- Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome 0 trials
- Spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome 0 trials
- Syndromic X-linked intellectual disability Najm type 0 trials
- Tubulinopathy-associated dysgyria 0 trials
-
Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types
25 sub-types
- Ehlers-Danlos syndrome, hypermobility type 15 trials
- Joint laxity, familial 14 trials
- Ehlers-Danlos syndrome, vascular type 6 trials Sub-types →
- Bethlem myopathy 2 0 trials
- COL1A1-related Ehlers-Danlos syndrome 0 trials Sub-types →
- COL1A2-related Ehlers-Danlos syndrome 0 trials Sub-types →
- Ehlers-Danlos syndrome due to tenascin-X deficiency 0 trials
- Ehlers-Danlos syndrome, Beasley-Cohen type 0 trials
- Ehlers-Danlos syndrome, arthrochalasia type 0 trials Sub-types →
- Ehlers-Danlos syndrome, autosomal dominant, type unspecified 0 trials
- Ehlers-Danlos syndrome, classic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, classic-like, 2 0 trials
- Ehlers-Danlos syndrome, classic-like, 3 0 trials
- Ehlers-Danlos syndrome, dermatosparaxis type 0 trials
- Ehlers-Danlos syndrome, fibronectinemic type 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type 1 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type, 2 0 trials
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- Ehlers-Danlos syndrome, periodontitis type 0 trials Sub-types →
- Ehlers-Danlos syndrome, spondylodysplastic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, vascular-like type 0 trials
- Ehlers-Danlos/osteogenesis imperfecta syndrome 0 trials Sub-types →
- X-linked Ehlers-Danlos syndrome 0 trials
- Brittle cornea syndrome 0 trials Sub-types →
- Spondylodysplastic Ehlers-Danlos syndrome 0 trials
-
Cutis laxa 37 trials · 39 incl. sub-types
2 sub-types
- Inherited cutis laxa 0 trials · 2 incl. sub-types Sub-types →
- Acquired cutis laxa 0 trials
-
Cleft palate 34 trials · 35 incl. sub-types
9 sub-types
- Isolated cleft palate 3 trials Sub-types →
- Submucosal cleft palate 1 trial
- Kuster syndrome 0 trials
- Rapp-Hodgkin syndrome 0 trials
- Bifid uvula 0 trials
- Cleft hard palate 0 trials
- Cleft palate with or without ankyloglossia, X-linked 0 trials
- Cleft soft palate 0 trials
- Soft and hard cleft palate 0 trials
-
Hereditary hemorrhagic telangiectasia 34 trials
5 sub-types
-
Infectious embryofetopathy 2 trials · 25 incl. sub-types
10 sub-types
- Congenital herpes virus infection 0 trials · 15 incl. sub-types Sub-types →
- Congenital syphilis 7 trials Sub-types →
- Congenital toxoplasmosis 2 trials
- Congenital Epstein-Barr virus infection 0 trials
- Congenital enterovirus infection 0 trials
- Congenital rubella syndrome 0 trials
- Congenital varicella syndrome 0 trials
- Fetal enterovirus syndrome 0 trials
- Fetal parainfluenza virus type 3 syndrome 0 trials
- Fetal parvovirus syndrome 0 trials
-
Toxic or drug-related embryofetopathy 2 trials · 21 incl. sub-types
22 sub-types
- Fetal alcohol syndrome 17 trials
- Fetal trimethadione syndrome 0 trials · 1 incl. sub-types Sub-types →
- Thalidomide embryopathy 1 trial
- Acitretin/etretinate embryopathy 0 trials
- Aminopterin/methotrexate embryofetopathy 0 trials
- Cocaine embryofetopathy 0 trials
- Diethylstilbestrol syndrome 0 trials
- Fetal carbamazepine syndrome 0 trials
- Fetal hydantoin syndrome 0 trials
- Fetal iodine syndrome 0 trials
- Fetal methylmercury syndrome 0 trials
- Fetal minoxidil syndrome 0 trials
- Fetal phenothiazine syndrome 0 trials
- Fetal valproate syndrome 0 trials
- Indomethacin embryofetopathy 0 trials
- Isotretinoin syndrome 0 trials
- Methimazole embryofetopathy 0 trials
- Mycophenolate mofetil embryopathy 0 trials
- Phenobarbital embryopathy 0 trials
- Propylthiouracil embryofetopathy 0 trials
- Toluene embryopathy 0 trials
- Vitamin K-antagonist embryofetopathy 0 trials
-
Abdominal wall malformation 6 trials · 17 incl. sub-types
4 sub-types
- Gastroschisis 11 trials Sub-types →
- Omphalocele 3 trials Sub-types →
- Body-stalk anomaly 0 trials
- Omphalomesenteric cyst 0 trials
-
Congenital anomaly of kidney and urinary tract 7 trials · 14 incl. sub-types
3 sub-types
-
Progeroid syndrome 3 trials · 11 incl. sub-types
16 sub-types
- Cockayne syndrome 6 trials Sub-types →
- Hutchinson-Gilford progeria syndrome 3 trials
- Werner syndrome 2 trials
- Fischer-Zirnsak progeroid syndrome 0 trials
- Fontaine progeroid syndrome 0 trials
- Garg-Mishra progeroid syndrome 0 trials
- Marbach-Rustad progeroid syndrome 0 trials
- Nestor-Guillermo progeria syndrome 0 trials
- RECON progeroid syndrome 0 trials
- Wiedemann-Rautenstrauch syndrome 0 trials
- XFE progeroid syndrome 0 trials
- Achalasia-progeroid syndrome 0 trials
- Mandibular hypoplasia-deafness-progeroid syndrome 0 trials
- Mandibuloacral dysplasia progeroid syndrome 0 trials
- Progeroid and marfanoid aspect-lipodystrophy syndrome 0 trials
- Progeroid facial appearance with hand anomalies 0 trials
-
Microtia 8 trials
1 sub-type
- Ear without helix 0 trials
-
PTEN hamartoma tumor syndrome 6 trials · 8 incl. sub-types
4 sub-types
-
Urogenital tract malformation 0 trials · 8 incl. sub-types
3 sub-types
- Fetal lower urinary tract obstruction 0 trials · 6 incl. sub-types Sub-types →
- Exstrophy-epispadias complex 1 trial · 3 incl. sub-types Sub-types →
- Isolated persistent urogenital sinus 0 trials
-
Hydrops fetalis 3 trials · 7 incl. sub-types
2 sub-types
- Non-immune hydrops fetalis 3 trials · 6 incl. sub-types Sub-types →
- Immune hydrops fetalis 0 trials
-
Angioosteohypertrophic syndrome 6 trials
-
Legius syndrome 5 trials
-
Nevoid basal cell carcinoma syndrome 5 trials
2 sub-types
- Basal cell nevus syndrome 1 0 trials
- Basal cell nevus syndrome 2 0 trials
-
Schwannomatosis 3 trials
4 sub-types
- 22q-related schwannomatosis 0 trials
- LZTR1-related schwannomatosis 0 trials
- SMARCB1-related schwannomatosis 0 trials
- Neurofibromatosis, type III, mixed central and peripheral 0 trials
-
Cysts and fistulae of the face and oral cavity 0 trials · 3 incl. sub-types
13 sub-types
- Familial thyroglossal duct cyst 2 trials
- First branchial cleft anomaly 1 trial
- Second branchial cleft anomaly 1 trial
- Cervical dermoid cyst 0 trials
- Cervicofacial fibrochondroma 0 trials
- Commissural lip fistula 0 trials
- Digestive duplication cyst of the tongue 0 trials
- Facial dermoid cyst 0 trials Sub-types →
- Fourth branchial cleft anomaly 0 trials
- Lower lip fistula 0 trials
- Nasal dorsum fistula/cyst 0 trials
- Pinnae fistula or cyst 0 trials
- Third branchial cleft anomaly 0 trials
-
Maffucci syndrome 2 trials
-
Neurofibromatosis-Noonan syndrome 2 trials
1 sub-type
- Watson syndrome 0 trials
-
Facial cleft 0 trials · 2 incl. sub-types
9 sub-types
- Bifid nose 0 trials · 1 incl. sub-types Sub-types →
- Commissural facial cleft 1 trial
- Tessier number 5 facial cleft 0 trials
- Tessier number 6 facial cleft 0 trials
- Coloboma of inferior eyelid 0 trials
- Coloboma of superior eyelid 0 trials
- Median cleft lip/mandibule 0 trials
- Median cleft of the upper lip and maxilla 0 trials
- Midline cervical cleft 0 trials
-
Anotia 1 trial
-
Diaphragmatic malformation 1 trial
-
Focal dermal hypoplasia 1 trial
-
Linear nevus sebaceous syndrome 1 trial
-
Macroglossia 1 trial
1 sub-type
- Congenital macroglossia 0 trials
-
Becker nevus syndrome 0 trials
1 sub-type
-
Desbuquois dysplasia 0 trials
2 sub-types
- Desbuquois dysplasia 1 0 trials
- Desbuquois dysplasia 2 0 trials
-
Larsen syndrome 0 trials
-
5 sub-types
-
Conjoined twins 0 trials
-
Cutis laxa - Marfanoid syndrome 0 trials
-
Hereditary neurocutaneous angioma 0 trials
-
Lethal Larsen-like syndrome 0 trials
-
Middle ear anomaly 0 trials
3 sub-types
-
Phakomatosis pigmentokeratotica 0 trials
-
Phakomatosis pigmentovascularis 0 trials
3 sub-types
- Phakomatosis cesioflammea 0 trials
- Phakomatosis cesiomarmorata 0 trials
- Phakomatosis spilorosea 0 trials
-
Pseudodiastrophic dysplasia 0 trials
Most studied deeper sub-types
-
Can a One-Time gene therapy fix fabry disease for years?
Cure Stopped earlyThis study follows people with Fabry disease who have already received FLT190, an experimental gene therapy that delivers a working copy of the GLA gene. The goal is to see how safe the treatment is over the long term and whether its effects last. Researchers will track participa…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a single gene infusion rewrite the story of fabry disease?
Cure Stopped earlyThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can an antiviral drug protect hearing in infants with congenital CMV?
Disease control Stopped earlyThis trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…
Phase 2 • Sponsor: Albert Park • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Immune cells take on nerve tumors: new trial launches
Disease control Stopped earlyThis early-stage trial is testing whether specially engineered immune cells (called CAR-T and CTL cells) and a dendritic cell vaccine can safely treat people with neurofibromatosis or schwannomatosis, conditions that cause nerve tumors. The study will enroll 100 participants aged…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Gene therapy aims to fix bone marrow failure in fanconi anemia
Disease control Stopped earlyThis trial tests a gene therapy for Fanconi anemia, a rare genetic disorder that causes bone marrow failure and increases cancer risk. Participants receive their own stem cells that have been genetically corrected with a lentiviral vector to fix the faulty FANCA gene. The study e…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New nasal spray aims to curb relentless hunger in rare genetic disorder
Disease control Stopped earlyThis study tests the long-term safety of a nasal spray called carbetocin for people with Prader-Willi syndrome who experience severe, constant hunger (hyperphagia). About 160 participants who completed a previous study will receive the spray three times daily. The goal is to see …
Phase 3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a gel cut down on skin cancer surgeries? new trial investigates
Disease control Stopped earlyThis trial tests a gel called patidegib applied to the face twice daily for 9 months in people who develop many basal cell carcinomas (a common skin cancer) but do not have Gorlin syndrome. The goal is to see if the gel reduces the number of new skin cancers that would normally r…
Phase 2 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Light-Activated cream could slow growth of NF1 skin tumors
Disease control Stopped earlyThis trial tests whether a light-activated cream (Levulan Kerastick) followed by red light therapy can slow the growth of benign skin tumors called neurofibromas in people with neurofibromatosis type 1 (NF1). About 30 participants aged 14 and older with superficial tumors on the …
Phase 2 • Sponsor: Donald Basel • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New cancer pill shows early promise, but trial halted
Disease control Stopped earlyThis early-stage trial tested an oral drug called TNO155, alone or with another drug (nazartinib), in 227 adults with advanced solid tumors like lung cancer, melanoma, and head/neck cancer. The main goal was to check safety and find the right dose. The study was terminated early,…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Real-World study tracks Selumetinib's impact on NF1 tumors in children
Disease control Stopped earlyThis study observes children aged 3 to 18 with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas and are starting treatment with selumetinib. Researchers will track how well the drug shrinks or stabilizes tumors, how long patients stay on tre…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for rare hunger disorder: drug shows promise in Long-Term trial
Disease control Stopped earlyThis study tests whether ARD-101 can safely reduce extreme hunger and food-related behaviors in people with Prader-Willi syndrome over 12 months. About 90 participants who completed a prior study will take the drug daily and visit the clinic regularly. The goal is to improve qual…
Phase 3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Experimental cancer drug study halted early
Disease control Stopped earlyThis early-stage study tested a new drug called PF-07284892, alone or with other medicines, in people with advanced solid tumors that had specific genetic changes. The goal was to find the safest dose and check for side effects. The study was stopped early, so results are limited…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Ankle cartilage repair therapy trial halted early
Disease control Stopped earlyThis study tested a treatment called Chondron, made from a patient's own cartilage cells, for repairing ankle cartilage defects. The trial aimed to see if the treatment could improve cartilage quality and ankle function over 18 months. However, the study was terminated early and …
Phase 3 • Sponsor: Cellontech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Hope fades: trial of Tay-Sachs drug venglustat terminated early
Disease control Stopped earlyThis Phase 3 trial tested an oral drug called venglustat in 75 adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that cause progressive nerve damage. The drug aimed to lower toxic fat buildup in the brain and slow disease worsening. However…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Custom-grown ear implant tracked for long-term safety and looks
Disease control Stopped earlyThis study followed one person with microtia (a small or missing outer ear) who had already received an AUR-201 implant — a 3D-printed ear made from their own cartilage cells. Researchers checked how well the implant kept its shape and whether any side effects appeared up to 96 w…
Phase 1/2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
3D-Printed ear implant made from your own cells tested in tiny trial
Disease control Stopped earlyThis trial tested a new ear implant called AUR-201 for people with a rare birth defect called microtia, where one ear is small or missing. The implant was custom-made using the patient's own cartilage cells and a 3D-printed scaffold. Only 3 people were enrolled before the study w…
Phase 1/2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Experimental ear implant tested in tiny study
Disease control Stopped earlyThis study tested an experimental implant called AUR-201 to rebuild the outer ear in people with unilateral microtia (one ear that is small or missing). Only 2 people enrolled before the study was stopped early. The goal was to check safety and see if the implant improved ear app…
Phase 1 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Bladder cancer drug combo study halted early
Disease control Stopped earlyThis study looked at whether adding an immunotherapy drug (pembrolizumab) to a targeted therapy (pemigatinib) works better than the targeted therapy alone or standard care for people with advanced bladder cancer that has a specific gene change (FGFR3). The study was stopped early…
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Targeted drug pemigatinib tested in tumors with FGFR mutations – trial stopped early
Disease control Stopped earlyThis phase 2 study tested the drug pemigatinib in 111 people with advanced solid tumors that have specific FGFR gene mutations or translocations. The goal was to see if the drug could shrink tumors. The trial was terminated early, so the full results are not available.
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental cancer drug INCB062079 tested in early trial
Disease control Stopped earlyThis early-phase trial tested a new drug called INCB062079 in 25 people with advanced liver cancer and other solid tumors. The main goal was to check safety and find the best dose. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Hope for rare hunger disorder: new drug enters final testing phase
Symptom relief Stopped earlyThis phase 3 trial tests whether ARD-101 can reduce the intense, constant hunger (hyperphagia) seen in Prader-Willi syndrome. About 90 participants will take either ARD-101 or a placebo daily for 12 weeks. Caregivers will track changes in hunger-related behaviors using a standard…
Phase 3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a scented fan ease breathlessness at the end of life?
Symptom relief Stopped earlyThis study looked at whether blowing a fan with aromatherapy on the face can help reduce breathlessness in people with terminal illness. The trial planned to enroll 26 adults who were near the end of life and had trouble breathing. Participants were randomly assigned to receive a…
Sponsor: Tsai-Wei Huang • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a common heart drug tame nosebleeds in rare disease?
Symptom relief Stopped earlyThis study tested whether propranolol, a beta-blocker usually used for heart conditions, can reduce nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder that causes abnormal blood vessels. Fifteen adults with HHT took either propranolol or a p…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Laser zaps belly skin – but trial fizzles out
Symptom relief Stopped earlyThis small study tested a special laser (violet and green light) to see if it could tighten loose skin on the belly. Only 9 people signed up, and the study was stopped early. Researchers planned to compare before-and-after photos to judge improvement, but the tiny size and early …
Sponsor: Erchonia Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
CBDV study for Prader-Willi syndrome halted early
Symptom relief Stopped earlyThis study tested whether a cannabis-derived compound called CBDV could safely reduce irritability in children and young adults with Prader-Willi syndrome. Only 6 people enrolled before the study was stopped early. The goal was to see if CBDV helped with mood and behavior problem…
Phase 2 • Sponsor: Eric Hollander • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Home infusions may help patients stick to treatment
Knowledge-focused Stopped earlyThis study looks at whether people with Fabry, Gaucher, or Hunter disease are more likely to continue their IV treatment when it's given at home versus at a hospital. Researchers will review existing data from 222 patients in Mexico. No new treatments are given; the goal is to un…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Ultrasound could uncover hidden vascular risks in turner syndrome
Knowledge-focused Stopped earlyThis study is looking at whether yearly ultrasound scans can detect blood vessel abnormalities throughout the body in women with Turner syndrome, not just in the heart area. Turner syndrome is a genetic condition that increases the risk of serious vascular problems, which can sho…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Gene Editing's lasting impact: a 10-Year safety watch
Knowledge-focused Stopped earlyThis study checks on people who previously received gene editing for hemophilia B or mucopolysaccharidosis (MPS) I or II. No new treatment is given; instead, participants are monitored for up to 10 years to see if any new health problems or worsening of existing conditions appear…
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused Stopped earlyThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Fabry disease sperm study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common sperm problems are in men with Fabry disease. Researchers planned to check sperm samples from 22 men aged 18 to 65. The study was stopped early, so results are limited.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain and eye clues to emotion recognition in autism and psychosis
Knowledge-focused Stopped earlyThis study aimed to understand why people with autism or schizophrenia sometimes struggle to recognize emotions on faces. Researchers used brain wave recordings (EEG) and eye-tracking to see how participants processed facial expressions. The study included people with autism, sch…
Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scientists dive into cells to unravel costello Syndrome's secrets
Knowledge-focused Stopped earlyThis study collects small skin samples from children aged 2 to 17 with Costello syndrome or a related condition. Researchers will analyze the cells to understand how a mutation in the HRAS gene affects energy use and mitochondria. The goal is to learn more about the disease's und…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Cleft jaw surgery study cut short: did it help patients?
Knowledge-focused Stopped earlyThis study aimed to see if orthognathic (jaw) surgery improves quality of life for people born with cleft lip and palate. Researchers planned to compare questionnaire scores before and 6 months after surgery in about 10 participants. The study was terminated early, so results are…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Why are people with this rare bone disorder prone to diabetes?
Knowledge-focused Stopped earlyThis pilot study aims to understand why people with pseudohypoparathyroidism type 1A (PHP1A) have a higher risk of type 2 diabetes. Researchers will measure insulin sensitivity and beta-cell function in 14 participants with PHP1A or related conditions, comparing them to matched h…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Superhero training for food allergy safety falls short
Knowledge-focused Stopped earlyThis study aimed to help children aged 6-8 from low-income families learn how to avoid foods they are allergic to. The program used fun, hands-on activities to teach safety skills. The study was stopped early, so we don't have clear results on whether it worked.
Sponsor: Kent State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for clues in rare genetic brain disorder
Knowledge-focused Stopped earlyThis study aimed to observe how MECP2 duplication syndrome progresses over time by measuring biological markers in spinal fluid and blood, and by tracking changes in development, behavior, and seizures. It enrolled 29 males aged 1 month to 65 years with a confirmed genetic diagno…
Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Tiny study on nerve stimulation for pain halted early
Knowledge-focused Stopped earlyThis study looked at a type of spinal cord stimulation (SCS) that doesn't cause tingling, called paresthesia-free SCS, in 10 adults with chronic pain. Researchers wanted to see how well it works and how it affects pain perception. The study was terminated early, so the findings a…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Heavy periods and loose joints: a hidden connection?
Knowledge-focused Stopped earlyThis study looked at women and girls aged 12 to 40 with heavy menstrual bleeding to see if they also have joint hypermobility (loose joints). Researchers wanted to find out if these two issues together might point to an underlying connective tissue disorder. The study was stopped…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Rare disease study aims to map MLIV's natural course
Knowledge-focused Stopped earlyThis study followed 7 people with Mucolipidosis Type IV (MLIV) to learn how the disease naturally progresses. Researchers used tests like neuropsychological exams, blood and urine tests, and brain MRIs to find better ways to measure the disease. The goal was to improve future cli…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
MRI scans aim to uncover hidden ear damage in CMV survivors
Knowledge-focused Stopped earlyThis study looked at whether people born with cytomegalovirus (CMV) infection who have hearing loss or balance problems also have a condition called endolymphatic hydrops (fluid buildup in the inner ear). Researchers used a special MRI scan with a contrast dye to check for this f…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Drug interaction study for radiprodil halted early
Knowledge-focused Stopped earlyThis early-stage study looked at how two common drugs (carbamazepine and itraconazole) change the levels of radiprodil in the blood of 30 healthy adults. The goal was to understand safety and dosing for future use in neurological conditions like tuberous sclerosis. However, the s…
Phase 1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC